These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16702880)

  • 41. Tris discriminates between the different alpha-glucosidase activities from extracts of human neutrophils.
    Ortiz de Apodaca MA; Fernandez E; de la Fuente G
    J Inherit Metab Dis; 1992; 15(2):213-9. PubMed ID: 1527988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presymptomatic late-onset Pompe disease identified by the dried blood spot test.
    Wagner M; Chaouch A; Müller JS; Polvikoski T; Willis TA; Sarkozy A; Eagle M; Bushby K; Straub V; Lochmüller H
    Neuromuscul Disord; 2013 Jan; 23(1):89-92. PubMed ID: 23062590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
    Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
    Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia.
    Pérez-López J; Selva-O'Callaghan A; Grau-Junyent JM; Gallego-Galindo L; Coll MJ; García-Morillo S; Torralba-Cabeza MA; Vilardell-Tarrés M
    Mol Genet Metab; 2015 Apr; 114(4):580-3. PubMed ID: 25752415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosing lysosomal storage disorders: Pompe disease.
    Bodamer OA; Dajnoki A
    Curr Protoc Hum Genet; 2012 Oct; Chapter 17():Unit17.11. PubMed ID: 23074069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Some properties of human liver acid alpha-glucosidase.
    Koster JF; Slee RG
    Biochim Biophys Acta; 1977 May; 482(1):89-97. PubMed ID: 16657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The maltase, glucoamylase and transglucosylase activities of acid -glucosidase from rabbit muscle.
    Palmer TN
    Biochem J; 1971 Oct; 124(4):713-24. PubMed ID: 5289198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Luminal starch substrate "brake" on maltase-glucoamylase activity is located within the glucoamylase subunit.
    Quezada-Calvillo R; Sim L; Ao Z; Hamaker BR; Quaroni A; Brayer GD; Sterchi EE; Robayo-Torres CC; Rose DR; Nichols BL
    J Nutr; 2008 Apr; 138(4):685-92. PubMed ID: 18356321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical Assessment of In Vitro Screening of α-Glucosidase Inhibitors from Plants with Acarbose as a Reference Standard.
    Miller N; Joubert E
    Planta Med; 2022 Oct; 88(12):1078-1091. PubMed ID: 34662924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry.
    Kishnani PS; Amartino HM; Lindberg C; Miller TM; Wilson A; Keutzer J
    Mol Genet Metab; 2014; 113(1-2):84-91. PubMed ID: 25085280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program.
    Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH
    Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. alpha-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose.
    Adisakwattana S; Charoenlertkul P; Yibchok-Anun S
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):65-9. PubMed ID: 18615280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
    Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT
    Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease.
    Tortorelli S; Eckerman JS; Orsini JJ; Stevens C; Hart J; Hall PL; Alexander JJ; Gavrilov D; Oglesbee D; Raymond K; Matern D; Rinaldo P
    Genet Med; 2018 Aug; 20(8):840-846. PubMed ID: 29095812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders.
    Gelb MH; Turecek F; Scott CR; Chamoles NA
    J Inherit Metab Dis; 2006; 29(2-3):397-404. PubMed ID: 16763908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
    Lorenzoni PJ; Kay CSK; Higashi NS; D'Almeida V; Werneck LC; Scola RH
    Arq Neuropsiquiatr; 2018 Apr; 76(4):247-251. PubMed ID: 29742245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetic studies on the substrate specificity and active site of rabbit muscle acid alpha-glucosidase.
    Matsui H; Sasaki M; Takemasa E; Kaneta T; Chiba S
    J Biochem; 1984 Oct; 96(4):993-1004. PubMed ID: 6394601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.
    Herzog A; Hartung R; Reuser AJ; Hermanns P; Runz H; Karabul N; Gökce S; Pohlenz J; Kampmann C; Lampe C; Beck M; Mengel E
    Orphanet J Rare Dis; 2012 Jun; 7():35. PubMed ID: 22676651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for late-onset Pompe disease in Finland.
    Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B
    Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
    Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
    Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.